These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7434566)

  • 1. The effect of ceruloplasmin on experimental infection with influenza virus APR 8/34 (H0N1) in the mouse.
    Samuel I; Tomas E; Istodor A; Bârnaure F; Cajal N
    Virologie; 1980; 31(3):221-5. PubMed ID: 7434566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of some drugs and of ceruloplasmin on experimental influenza APR 8/34 (H0N1) infection in the mouse.
    Tomas E; Samuel I; Bârnaure F
    Virologie; 1979; 30(3):233-4. PubMed ID: 538885
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of ceruloplasmin on AoPR8 influenza virus infection in embryonate eggs and mice.
    Tomas E; Samuel I
    Virologie; 1975; 26(1):57-61. PubMed ID: 1216690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.
    Tamura S; Ito Y; Asanuma H; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T
    J Immunol; 1992 Aug; 149(3):981-8. PubMed ID: 1634780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the effect of cellular and viral nucleic acids against experimental influenza virus A/PR8/34 (H1N1) infection in mice.
    Repanovici R; Moisa I; Mihalache O; Iacobescu I; Burducea O; Iliescu R; Popa LM; Cajal N
    Virologie; 1983; 34(3):183-9. PubMed ID: 6195810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ceruloplasmin on the multiplication and on some biological and physico-chemical characteristics of influenza virus A/PR8/34 (H0N1) cultivated in chorioallantoic membrane fragments. Note 2. Modifications occurring in the course of serial passages.
    Samuel I; Tomas E; Bârnaure F; Cajal N
    Virologie; 1982; 33(2):147-52. PubMed ID: 7147703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic effect of a Beta vulgaris extract on experimental influenza infection in mice.
    Prahoveanu E; Eşanu V; Anton G; Frunzulică S
    Virologie; 1986; 37(2):121-3. PubMed ID: 3727395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of inactivated influenza virus vaccine against lethal influenza virus infection in diabetic mice.
    Zhu Q; Chang H; Chen Y; Fang F; Xue C; Zhang F; Qiu M; Wang H; Wang B; Chen Z
    Biochem Biophys Res Commun; 2005 Apr; 329(1):87-94. PubMed ID: 15721277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antioxidant and immunomodulating effect of ceruloplasmin in experimental influenza].
    Berdinskikh NK; Savtsova ZD; Sanina OL; Antonenko SG; Orlovskiĭ AA; Zaritskaia MIu; Iudina OIu
    Biull Eksp Biol Med; 1994 Sep; 118(9):285-7. PubMed ID: 7819562
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationships between ceruloplasmin and viral immunity.
    Samuel I; Tomas E
    Virologie; 1982; 33(1):63-72. PubMed ID: 6280375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ceruloplasmin on the multiplication and on some biological and physico-chemical characteristics of influenza virus A/PR8/34 (H0N1) cultivated on chorioallantoic membrane fragments. Note 1. Kinetics of virus multiplication and of some biological characteristics in the presence and absence of ceruloplasmin.
    Tomas E; Samuel I; Bârnaure F; Cajal N
    Virologie; 1982; 33(2):139-46. PubMed ID: 7147702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza hemagglutinin vaccine.
    Tamura SI; Asanuma H; Ito Y; Hirabayashi Y; Suzuki Y; Nagamine T; Aizawa C; Kurata T; Oya A
    Eur J Immunol; 1992 Feb; 22(2):477-81. PubMed ID: 1537382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection.
    Tsurita M; Kurokawa M; Imakita M; Fukuda Y; Watanabe Y; Shiraki K
    J Pharmacol Exp Ther; 2001 Jul; 298(1):362-8. PubMed ID: 11408563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
    Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A
    Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity to influenza infection of X-ray-irradiated animals and the protective effect of a thymus extract].
    Prahoveanu E; Boieru V; Petrescu A
    Virologie; 1986; 37(4):269-77. PubMed ID: 3548032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an aqueous propolis extract, of rutin and of a rutin-quercetin mixture on experimental influenza virus infection in mice.
    Eşanu V; Prahoveanu E; Crişan I; Cioca A
    Virologie; 1981; 32(3):213-5. PubMed ID: 7303493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice.
    Hovden AO; Cox RJ; Madhun A; Haaheim LR
    Scand J Immunol; 2005 Oct; 62(4):342-52. PubMed ID: 16253121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A probable model of the inhibitory action of ceruloplasmin on the multiplication of some myxo- and paramyxoviruses.
    Tomas E; Samuel I
    Virologie; 1980; 31(2):131-4. PubMed ID: 7405012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations about the possible function of ceruloplasmin in influenza and parainfluenza virus infections.
    Tomas E; Topârceanu F
    Virologie; 1986; 37(4):279-87. PubMed ID: 3029949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.